Abstract
AbstractThe opioid crisis in the United States is primarily driven by the highly potent synthetic opioid fentanyl leading to >70,000 overdose deaths annually; thus, new therapies for fentanyl overdose are urgently needed. Here, we present the first clinic-ready, fully human monoclonal antibody CSX-1004 with picomolar affinity for fentanyl and related analogs. In mice CSX-1004 reverses fentanyl antinociception and the intractable respiratory depression caused by the ultrapotent opioid carfentanil. Moreover, toxicokinetic evaluation in a repeat-dose rat study and human tissue cross-reactivity study reveals a favorable pharmacokinetic profile of CSX-1004 with no safety-related issues. Using a highly translational non-human primate (NHP) model of respiratory depression, we demonstrate CSX-1004-mediated protection from repeated fentanyl challenges for 3-4 weeks. Furthermore, treatment with CSX-1004 produces up to a 15-fold potency reduction of fentanyl in NHP respiration, antinociception and operant responding assays without affecting non-fentanyl opioids like oxycodone. Taken together, our data establish the feasibility of CSX-1004 as a promising candidate medication for preventing and reversing fentanyl-induced overdose.
Funder
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary
Reference56 articles.
1. C. J. Ahmad F. B., Rossen L. M., Sutton P., “Provisional drug overdose death counts,” (National Center for Health Statistics, CDC) https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm. 2023.
2. Janssen, P. A. A review of the chemical features associated with strong morphine-like activity. Br. J. Anaesth. 34, 260–268 (1962).
3. Kelly, E. et al. The anomalous pharmacology of fentanyl. Br. J. Pharm. 180, 797–812 (2023).
4. Hill, R., Santhakumar, R., Dewey, W., Kelly, E. & Henderson, G. Fentanyl depression of respiration: comparison with heroin and morphine. Br. J. Pharm. 177, 254–266 (2020).
5. Pergolizzi, J. V. Jr., Webster, L. R., Vortsman, E., Ann LeQuang, J. & Raffa, R. B. Wooden chest syndrome: the atypical pharmacology of fentanyl overdose. J. Clin. Pharm. Ther. 46, 1505–1508 (2021).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献